Explore European Union Legislation by Asking a Legal Question
assisted-checkbox
filter-instruction-1
positive-filters
negative-filters
act-filter tabs-all
parameters-title
query
assisted-checkbox: ✅
result-title
total 16
Council Regulation (EC) No 467/97 of 3 March 1997 providing for duty-free treatment for specified pharmaceutical active ingredients bearing an 'international non-proprietary name' (INN) from the World Health Organization and specified products used for the manufacture of finished pharmaceuticals and withdrawing duty-free treatment as pharmaceutical products from certain INNs whose predominant use is not pharmaceutical article annex_II CELEX: 31997R0467 Additional pharmaceutical intermediates, i.e. compounds used for the manufacture of finished pharmaceutical products, to receive duty-free treatment
CN code
CAS RN
Name
2843 30 00
12192-57-3
(alpha-D-glucopyranosylthio) gold
2903 69 90
42074-68-0
1-chloro-2-(chlorodiphenylmethyl) benzene
76283-09-5
alpha,4-dibromo-2-fluorotoluene
2906 29 90
104265-58-9
2-[(1 S,2R)-6-fluoro-2-hydroxy-1 -isopropyl-1,2,3,4-tetrahydro-2-naphthyl] ethyl p-toluenesulfonate
2907 29 90
700-13-0
2,3,5-tximethylhydroquinone
2909 50 90
63659-16-5
4-[2-(cyclopropylmethoxy) ethyl] phenol
2914 40 90
80-75-1
11-alpha-hydroxypregn-4-ene-3,20-dione
2914 50 00
2107-69-9
5,6-dimethoxyindan-1 -one
24916-90-3
9-beta,11-beta-epoxy-17,21-dihydroxy-l6-alpha-methylpregna-l,4-diene-3,20-dione
2914 70 90
83881-08-7
21-chloro-9-beta, 11 -beta-epoxy-17-hydroxy-16-alpha-methylpregna-1,4-diene-3,20-dione
2915 39 90
979-02-2
20-oxopregna-5,l 6-dien-3-beta-yl acetate
2915 90 20
638-41-5
pentyl chloroformate
2916 39 00
49708-81-8
trans-4-(p-chlorophenyl)cyclohexanecarboxylic acid
2917 19 90
48059-97-8
(E)-oct-4-ene-1,8-dioic acid
71170-82-6
triethyl 3-bromopropane-1,1,1-tricarboxylate
2917 39 80 |
Council Regulation (EC) No 467/97 of 3 March 1997 providing for duty-free treatment for specified pharmaceutical active ingredients bearing an 'international non-proprietary name' (INN) from the World Health Organization and specified products used for the manufacture of finished pharmaceuticals and withdrawing duty-free treatment as pharmaceutical products from certain INNs whose predominant use is not pharmaceutical article annex_II CELEX: 31997R0467 27932-00-9
indan-5-yl hydrogen phenylmalonate
2918 13 00
2743-38-6
dibenzoyl-L-tartaric acid
2918 17 00
4358-88-7
ethyl DL-mandelate
2918 19 80
56188-04-6
{(1 R,3R,5S)-3,5-dihydroxy-2-[(E)-(3S)-3-hydroxyoct-1 -enyl]cyclopentyl}acetic acid
2918 29 90
167678-46-8
3-chloroformyl-o-tolyl acetate
2918 30 00
56105-81-8
(R)-2-(3-benzoylphenyl) propionic acid
22161-86-0
(RS)-2-(3-benzoylphenyl) propionic acid
78834-75-0
enthyl 7-chloro-2-oxoheptanoate
1944-63-4
3-[(3aS,4S,7aS)-7a-methyl-1,5-dioxooctahydro-1 H-inden-4-yl]propionic acid
39562-17-9
methyl 2-(3-nitrobenzylidene)-3-oxobutyrate
2918 90 90
26159-31-9
(RS)-2-(6-methoxy-2-naphthyl)propionic acid
105560-93-8
methyl (2R,3S)-2,3-epoxy-3-(4-methoxyphenyl) propionate
40098-26-8
methyl 7-[(3RS)-3-hydroxy-5-oxocyclopent-1-enyl]heptanoate
2921 19 80
4261-68-1
(2-chloroethyl) diisopropylamine hydrochloride
2921 59 90
122-75-8
N, N'-dibenzylethylenediammonium di (acetate)
2922 19 00
126456-43-7
(1S,2R)-1-aminoindan-2-ol
68047-07-4
4'-[2-(dimethylamino) ethoxy]-2-phenylbutyrophenone
2922 30 00
784-38-3
2-amino-5-chloro-2'-fluorobenzophenone
156732-13-7 |
Council Regulation (EC) No 467/97 of 3 March 1997 providing for duty-free treatment for specified pharmaceutical active ingredients bearing an 'international non-proprietary name' (INN) from the World Health Organization and specified products used for the manufacture of finished pharmaceuticals and withdrawing duty-free treatment as pharmaceutical products from certain INNs whose predominant use is not pharmaceutical article annex_II CELEX: 31997R0467 (S)-5-amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one
2922 49 70
37441-29-5
5-amino-2,4,6-triiodoisophthaloyl dichloride
42854-62-6
benzyl L-alaninate--p-toluenesulfonic acid (1:1)
39878-87-0
(-)-alpha-(chloroformyl) benzylammonium chloride
54527-73-0
2-(N-methylbenzylamino) ethyl 3-aminobut-2-enoate
81677-60-3
methyl (4-nitrophenyl)-L-alaninate
949-99-5
3-(4-nitrophenyl)-L-alanine
2924 10 00
153758-31-7
(2S)-2-amino-3-hydroxy-N-pentylpropionamide--oxalic acid (1:1)
138531-07-4
L-lysyl-L-leucyl-L-leucyl-L-leucyl-L-leucyl-L-lysyl-L-leucyl-L-leucyl-L-leucyl-L-leucyl-L-lysyl-L-leucyl-o
L-leucyl-L-leucyl-L-leucyl-L-lysyl-L-leucyl-L-leucyl-L-leucyl-L-leucyl-L-lysine
2924 29 90
40188-45-2
3'-acetyl-4'-hydroxybutyranilide
1149-26-4
N-(benzyloxycarbonyl)-L-valine
116661-86-0
(2S,3S)-3-(tert-butoxycarbonylamino)-2-hydroxy-4-phenylbutyric acid
144163-85-9
tert-butyl [(1S,3S,4S)-4-amino-1-benzyl-3-hydroxy-5-phenylpentyl] carbamate
149451-80-9
tert-butyl [(1S,2S)-1-benzyl-2,3-dihydroxypropyl] carbamate
98737-29-2
tert-butyl {(S)-alpha-[(S)-oxiranyl]phenethyl}carbamate
0-00-0
2-chloro-N-[2-(2-chlorobenzoyl)-4-nitrophenyl] acetamide
125971-96-2 |
Council Regulation (EC) No 467/97 of 3 March 1997 providing for duty-free treatment for specified pharmaceutical active ingredients bearing an 'international non-proprietary name' (INN) from the World Health Organization and specified products used for the manufacture of finished pharmaceuticals and withdrawing duty-free treatment as pharmaceutical products from certain INNs whose predominant use is not pharmaceutical article annex_II CELEX: 31997R0467 2-[alpha-(4-fluorobenzoyl)benzyl]-4-methyl-3-oxovaleranilide
32981-85-4
methyl (2R,3S)-3-benzamido-2-hydroxy-3-phenylpropionate
2925 19 80
151860-15-0
meso-N-benzyl-3-nitrocyclopropane-1,2-dicarboximide
97338-03-9
ethyl (S)-3-(4-aminopheynl)-2-phthalimidopropionate hydrochloride
94213-26-0
ethyl (S)-3-{4-[bis(2-chloroethyl)amino]phenyl}-2-phthalimidopropionate hydrochloride
2926 90 80
58311-73-2
(Z)-(2-cyanovinyl)trimethylammonium p-toluenesulfonate
133481-10-4
ethyl (l-cyanocyclohexl)acetate
123632-23-5
4-(2,2,3,3-tetrafluoropropoxy)cinnamonitrile
2928 00 90
94213-23-7
(Z)-[cyano(2,3-dichlorophenyl)methylene]carbazamidine
2930 90 16
159453-24-4
N-(benzyloxycarbonyl)-S-phenyl-L-cysteine
2930 90 70
159878-02-1
benzyl (1 R,2S)-3-chloro-2-hydroxy-1 -(phenylthiomethyl)propylcarbamate
136511-43-8
ethyl N-{2-[(acetylthio)methyl]-3-(o-tolyl)-1-oxopropyl}-L-methionate
2932 19 00
97148-39-5
ammonium (Z)-2-methoxyimino-2-(2-furyl)acetate
2932 29 80
517-23-7
alpha-acetyl-gamma-butyrolactone
6559-91-7
4'-demethylepipodophyllotoxin
39521-49-8
(3aR,4bS,4R,4aS,5aS)-4-(5,5-dimethyl-1,3-dioxolan-2-yl)hexahydrocyclopropa[3,4]cyclopenta[l,2-b]furan-o 2(3H)-one
39746-01-5 |
Council Regulation (EC) No 467/97 of 3 March 1997 providing for duty-free treatment for specified pharmaceutical active ingredients bearing an 'international non-proprietary name' (INN) from the World Health Organization and specified products used for the manufacture of finished pharmaceuticals and withdrawing duty-free treatment as pharmaceutical products from certain INNs whose predominant use is not pharmaceutical article annex_II CELEX: 31997R0467 (3aR,4R,5R,6aS)-4-formyl-2-oxohexahydro-2H-cyclopenta[b]furan-5-yl benzoate
976-70-5
3-oxopregn-4-ene-21,17-alpha-carbolactone
2932 99 50
32981-86-5
10-deacetylbaccatin III
2932 99 70
7512-17-6
2-acetamido-2-deoxy-beta-D-glucopyranose
79944-37-9
trans-6-amino-2,2-dimethyl-1,3-dioxepan-5-ol
125971-94-0
tert-butyl [(4R,6R)-6-(cyanomethyl)-2,2-dimethyl-1,3-dioxolan-4-yl]acetate
467-55-0
3-beta-hydroxy-5-alpha-spirostan-12-one
533-31-3
3,4-(methylenedioxy)phenol
2933 11 90
6150-97-6
magnesium bis [(2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1 H-pyrazol-4-yl)methylamino]methane- sulfonate
2933 19 90
27511-79-1
3-aminopyrazole-4-carboxamide hemisulfate
2933 29 90
4897-25-0
5-chloro-1-methyl-4-nitroimidazole
2933 39 95
142057-79-2
(RS)-2[(1 -benzyl-4-piperidyl)methyl]-5,6-dimethoxyindan-l -one
120014-07-5
2-[(l-benzyl-4-piperidyl)methylene]-5,6-dimethoxyindan-1-one
6935-27-9
benzyl(2-pyridy l)amine
87848-95-1
6-bromo-2-pyridyl-p-tolyl ketone
32998-95-1
N-(tert-butyl)-3-methylpyridine-2-carboxamide
84449-80-9
1-[2-(4-carboxyphenoxy)ethyl]piperidinium chloride
83949-32-0
4-carboxy-4-phenylpiperidinium p-toluenesulfonate
38092-89-6 |
Council Regulation (EC) No 467/97 of 3 March 1997 providing for duty-free treatment for specified pharmaceutical active ingredients bearing an 'international non-proprietary name' (INN) from the World Health Organization and specified products used for the manufacture of finished pharmaceuticals and withdrawing duty-free treatment as pharmaceutical products from certain INNs whose predominant use is not pharmaceutical article annex_II CELEX: 31997R0467 8-chloro-6,11-dihydro-11-(l-methyl-4-piperidylidene)-5H-benzo[5,6]cyclohepta[l,2-b]pyridine
31255-57-9
3-[2-(3-chlorophenyl)ethyl]pyridine-2-carbonitrile
107256-31-5
3-[2-(3-chlorophenyl)ethyl]-2-pyridyl 1 -methyl-4-piperidyl ketone hydrochloride
6298-19-7
2-chloro-3-pyridylamine
5424-11-3
2,2-diphenyl-4-piperidinovaleronitrile
108555-25-5
1-[2-(4-methoxyphenyl)ethyl]-4-piperidylamine dihydrochloride
4046-24-6
5-(l -methyl-4-piperidyl)-5H-dibenzo[a,d]cyclohepten-5-ol hydrochloride
139886-04-7
1-methyl-1,2,5,6-tetrahydropyridine-3-carbaldehyde (E)-O-methyloxime hydrochloride
70708-28-0
1-(2-pyridyl)-3-(pyrrolidin-1-yl)-1-(p-tolyl)propan-1-ol
1619-34-7
quinuclidin-3-ol
2933 40 10
105956-96-5
7-[3-(tert-butoxycarbonylamino)pyrrolidin-1-yl]-8-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroc quinoline-3-carboxylic acid
86393-33-1
7-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
112811-72-0
1-cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
98349-25-8
ethyl 1 -cyclopropyl-6,7-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylate
2933 40 90
159878-04-3 |
Council Regulation (EC) No 467/97 of 3 March 1997 providing for duty-free treatment for specified pharmaceutical active ingredients bearing an 'international non-proprietary name' (INN) from the World Health Organization and specified products used for the manufacture of finished pharmaceuticals and withdrawing duty-free treatment as pharmaceutical products from certain INNs whose predominant use is not pharmaceutical article annex_II CELEX: 31997R0467 benzyl (1S,2S)-3-[3S,4aS,8aS)-3-tert-butylcarbamoylperhydro-2-isoquinolyl]-2-hydroxy-1-(phenylthioc methyl)propylcarbamate
159989-64-7
(3S,4aS,8aS)-N-(tert-butyl)-2-[(2S,3S)-2-hydroxy-3-(3-hydroxy-2-methylbenzamido)-4-(phenylthio)butyl] perhydroisoquinoline-3-carboxamide
159989-65-8
(3S,4aS,8aS)-N-(tert-butyl)-2-[(2S,3S)-2-hydroxy-3-(3-hydroxy-2-methylbenzamido)-4-(phenylthio)butyl] perhydroisoquinoline-3-carboxamide—methanesulfonic acid (1:1)
120578-03-2
3-[(E)-2-(7-chloro-2-quinolyl)vinyl]benzaldehyde
1087-69-0
(9S,13S,14S)-3-methoxymorphinan hydrochloride
64228-78-0
pentamethylene bis {3-[10-(3,4-dimethoxybenzyl)-6,7-dimethoxy-1,2,3,4-tetrahydro-2-isoquinolyl] propionate]- -oxalic acid (1:2)
2933 59 70
75128-73-3
2-[(2-acetamido-6-oxo-6,9-dihydro-1H-purin-9-yl)methoxy]ethyl acetate
3056-33-5
N-(9-acetyl-6-oxo-6,9-dihydro-1H-purin-2-yl)acetamide
10310-21-1
2-amino-6-chloropurine
124832-31-1
2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-(benzyloxycarbonyl)-L-valinate
150378-17-9
(2R,4S)-2-benzyl-5-[2-(tert-butylcarbamoyl)-4-(3-pyridylmethyl)piperazin-1-yl]-4-hydroxy-N-[(1S,2R)-2-hydroxyindan-1-yl]valeramide
157810-81-6 |
Council Regulation (EC) No 467/97 of 3 March 1997 providing for duty-free treatment for specified pharmaceutical active ingredients bearing an 'international non-proprietary name' (INN) from the World Health Organization and specified products used for the manufacture of finished pharmaceuticals and withdrawing duty-free treatment as pharmaceutical products from certain INNs whose predominant use is not pharmaceutical article annex_II CELEX: 31997R0467 (2R,4S)-2-benzyl-5-[2-(tert-butylcarbamoyl)-4-(3-pyridylmethyl)piperazin-1-yl]-4-hydroxy-N-[(lS,2R)-c 2-hydroxyindan-1-yl]valeramide sulfate
150323-35-6
(3S)-1-(tert-butoxycarbonyl)-3-(tert-butylcarbamoyl)piperazine
41202-32-8
1-(2-chlorophenyl)piperazine hydrochloride
13078-15-4
1-(3-chlorophenyl)piperazine hydrochloride
71-30-7
cytosine
149062-75-9
1,3-dichloro-6,7,8,9,1 0,1 2-hexahydroazepino[2,1 -b]quinazoline hydrochloride
41202-77-1
1-(2,3-dichlorophenyl)piperazine hydrochloride
56177-80-1
2-ethoxy-5-fluoropyrimidin-4(1 H)-one
112733-45-6
ethyl (7-chloro-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-l -yl)acetate
59703-00-3
4-ethyl-2,3-dioxopiperazine-l-carbonyl chloride
64090-19-3
1-(4-fluorophenyl)piperazine dihydrochloride
147539-21-7
isopropyl[2-(piperazin-1-yl)-3-pyridyl]amine
35386-24-4
1-(2-methoxyphenyl)piperazine
5464-78-8
1-(2-methoxyphenyl)piperazine hydrochloride
145012-50-6
(7RS,9aRS)-perhydropyrido[l,2-a]pyrazin-7-ylmethanol
2210-93-7
1-phenylpiperazinium chloride
111641-17-9
4-(piperazin-1-yl)-2,6-bis(pyrrolidin-1-yl)pyrimidine
68-94-0
purin-6(1 H)-one
70849-60-4
1-(o-tolyl)piperazine hydrochloride
2933 69 80
58909-39-0 |
Council Regulation (EC) No 467/97 of 3 March 1997 providing for duty-free treatment for specified pharmaceutical active ingredients bearing an 'international non-proprietary name' (INN) from the World Health Organization and specified products used for the manufacture of finished pharmaceuticals and withdrawing duty-free treatment as pharmaceutical products from certain INNs whose predominant use is not pharmaceutical article annex_II CELEX: 31997R0467 tetrahydro-2-methyl-3-thioxo-1,2,4-triazine-5,6-dione
2933 79 00
135297-22-2
(3S,4R)-3-[(R)-1-(tert-butyldimethylsilyloxy)ethyl]-4-[(lR,3S)-3-methoxy-2-oxocyclohexyl]azetidin-2-one
141646-08-4
1-|[(cyclohexyloxy)carbonyl]oxy}ethyl 1 -(1 -hydroxyethyl)-5-methoxy-2-oxo-1,2,5,6,7,8,8 a,8b-octahydroazeto*c [2,1 -a]isoindole-4-carboxylate
132127-34-5
(3R,4S)-3-hydroxy-4-phenylazetidin-2-one
75363-99-4
p-nitrobenzyl (2R,5R,6S)-6-[(R)-1-hydroxyethyl]-3,7-dioxo-1-azabicyclo[3.2.0]heptane-2-carboxylate
141316-45-2
potassium 1 -(1 -hydroxyethyl)-5-methoxy-2-oxo-1,2,5,6,7,8,8 a,8b-octahydroazeto[2,1 -a]isoindole-4-carbc oxylate
2933 90 60
59467-64-0
[7-chloro-5-(2-fluorophenyl)-2,3-dihydro-1H-1,4-benzodiazepin-2-yl]methylamine
59469-29-3
[7-chloro-5-(2-fluorophenyl)-2,3-dihydro-1 H-l,4-benzodiazepin-2-ylmethyl]ammonium bis(maleate)
59467-69-5
8-chloro-6-(2-fluorophenyl)-1-methyl-3a,4-dihydro-3H-imidazo[l,5-a][l,4]benzodiazepine
59469-63-5
7-chloro-5-(2-fluorophenyl)-3-methyl-2-(nitromethylene)-2,3-dihydro-1 H-1,4-benzodiazepine 4-oxide
59467-63-9
7-chloro-5-(2-fluorophenyl)-2(nitromethylene)-2,3-dihydro-1 H-1,4-benzodiazepine
2933 90 95
130404-91-0 |
Council Regulation (EC) No 467/97 of 3 March 1997 providing for duty-free treatment for specified pharmaceutical active ingredients bearing an 'international non-proprietary name' (INN) from the World Health Organization and specified products used for the manufacture of finished pharmaceuticals and withdrawing duty-free treatment as pharmaceutical products from certain INNs whose predominant use is not pharmaceutical article annex_II CELEX: 31997R0467 N-[(R)-2-({(R)-2-[(2-adamantyloxycarbonyl)amino]-3-(lH-indol-3-yl)-2-methyl-1-oxopropyl}amino)-1- phenylethyl]succinamic acid-1-deoxy-1-methylamino-D-glucitol (1:1)
122536-48-5
3-[(S)-3-(L-alanylamino)pyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3- carboxylic acid hydrochloride
122536-91-8
7-{(S)-3-[(S)-2-(tert-butoxycarbonylamino)-1-oxopropylamino]pyrrolidin-1-yl}-1-cyclopropyl-6-fluoro-4- oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
134575-17-0
tert-butyl meso-3-azabicyclo[3.1.0]hex-6-ylcarbamate
122536-66-7
tert-butyl [(S)-1-methyl-2-oxo-2-[(S)-pyrrolidin-3-ylamino]ethyl}carbamate
140629-77-2
tert-butyl [(RS)-pyrrolidin-3-yl] carbamate
100361-18-0
7-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
38150-27-5
5-chloro-2-[3-(hydroxymethyl)-5-methyl-4H-1,2,4-triazol-4-yl]ben2Ophenone
36916-19-5
5-chloro-2-(3-methyl-4H-1,2,4-triazol-4-yl)benzophenone
54196-62-2
2',5-dichloro-2-[3-(hydroxymethyl)-5-methyl-4H-1,2,4-triazol-4-yl]benzophenone
54196-61-1
2',5-dichloro-2-(3-methyl-4H-1,2,4-triazol-4-yl)benzophenone
141113-28-2 |